About SIRS-Lab

SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening infections, one of the major causes of death in hospitals across the world. SIRS-Lab's vision is to support clinicians in their bedside decisions by providing them with fast and reliable high-performance point of care systems and thus, to improve therapeutic impact and reduce the mortality rate of patients. Founded in 2000 by S. Russwurm, K. Reinhart, E. Straube and H.-P. Saluz, SIRS-Lab employs today 45 people. The company currently commercializes VYOO, a molecular diagnostic test for the rapid identification of sepsis causing bacteria and fungi. Sepsis is one of the major causes of death in hospitals.

website icon
Website
employees icon
Employees
industry icon
Industry
IT Services and IT Consulting
location icon
Phone number
49 3641 31 03 100
location icon
Headquarter
Jena, Thuringen
description icon
Founded
2000

SIRS-Lab Alternatives

Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics
Industry
Therapeutics

Frequently Asked Questions about SIRS-Lab

Who are the decision makers in SIRS-Lab?

The decision makers in SIRS-Lab are Britta Wlotzka, etc. Click to Find SIRS-Lab decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more